DCLA
CL icon

Douglas C. Lane & Associates’s Colgate-Palmolive CL Stock Holding History

Douglas C. Lane & Associates’s Portfolio CL Stock Details CL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		$12.5M Sell
187,698
-5,070
-3% -$337K 0.34% 94
2015
Q3 		$12.2M Sell
192,768
-6,816
-3% -$445K 0.35% 94
2015
Q2 		$13.1M Sell
199,584
-2,711
-1% -$184K 0.35% 92
2015
Q1 		$14M Sell
202,295
-1,288
-0.6% -$89K 0.37% 91
2014
Q4 		$14.1M Sell
203,583
-810
-0.4% -$54.7K 0.38% 91
2014
Q3 		$13.3M Buy
204,393
+1,040
+0.5% +$68.6K 0.4% 87
2014
Q2 		$13.9M Sell
203,353
-4,522
-2% -$303K 0.42% 82
2014
Q1 		$13.5M Sell
207,875
-930
-0.4% -$58.6K 0.43% 80
2013
Q4 		$13.6M Buy
208,805
+787
+0.4% +$50.4K 0.45% 83
2013
Q3 		$12.3M Sell
208,018
-1,954
-0.9% -$116K 0.45% 84
2013
Q2 		$12M Buy
+209,972
New +$12.5M 0.47% 83

Other funds holding CL

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Douglas C. Lane & Associates's CL Position: Q4 2015 in Review

Douglas C. Lane & Associates reduced its Colgate-Palmolive (CL) stake by 2.6% in Q4 2015, selling an estimated $337K and leaving 187,698 shares worth $12.5M. The position accounts for 0.34% of the portfolio, ranked #94.

Douglas C. Lane & Associates first reported a position in CL in Q2 2013 and has held it in 11 quarters since. The position peaked at $14.1M in Q4 2014. 1,254 funds tracked by Wall St. Rank hold CL as of Q4 2015.

  • Douglas C. Lane & Associates held 187,698 shares of Colgate-Palmolive worth $12.5M as of Q4 2015.
  • Douglas C. Lane & Associates sold 5,070 Colgate-Palmolive shares in Q4 2015, an estimated $337K.
  • Colgate-Palmolive made up 0.34% of Douglas C. Lane & Associates's portfolio in Q4 2015, its #94 holding.
  • Douglas C. Lane & Associates first reported a position in Colgate-Palmolive in Q2 2013 and has held it in 11 quarters since.
  • Douglas C. Lane & Associates's Colgate-Palmolive position peaked at $14.1M in Q4 2014.
  • 1,254 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q4 2015.

Based on Douglas C. Lane & Associates's 13F filing for Q4 2015, filed 25 Jan 2016.